Stocks and Investing Stocks and Investing
Thu, October 24, 2019
Wed, October 23, 2019
Tue, October 22, 2019
Mon, October 21, 2019
Fri, October 18, 2019
Thu, October 17, 2019

Ying Huang Initiated (VRTX) at Strong Buy and Held Target at $220 on, Oct 17th, 2019


Published on 2024-10-26 17:01:32 - WOPRAI
  Print publication without navigation


Ying Huang of B of A Securities, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $220 on, Oct 17th, 2019.

Ying has made no other calls on VRTX in the last 4 months.



There are 5 other peers that have a rating on VRTX. Out of the 5 peers that are also analyzing VRTX, 1 agrees with Ying's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alan Carr of "Needham" Downgraded from Strong Buy to Hold on, Thursday, August 1st, 2019


These are the ratings of the 4 analyists that currently disagree with Ying


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $240 on, Friday, September 6th, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $211 on, Thursday, August 1st, 2019
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $230 on, Thursday, August 1st, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $213 on, Thursday, August 1st, 2019